BE863368A - Nouveau vaccin - Google Patents

Nouveau vaccin

Info

Publication number
BE863368A
BE863368A BE184675A BE184675A BE863368A BE 863368 A BE863368 A BE 863368A BE 184675 A BE184675 A BE 184675A BE 184675 A BE184675 A BE 184675A BE 863368 A BE863368 A BE 863368A
Authority
BE
Belgium
Prior art keywords
new vaccine
vaccine
new
Prior art date
Application number
BE184675A
Other languages
English (en)
French (fr)
Inventor
G Bijlenga
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of BE863368A publication Critical patent/BE863368A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
BE184675A 1977-01-26 1978-01-26 Nouveau vaccin BE863368A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3258/77A GB1596653A (en) 1977-01-26 1977-01-26 Vaccine

Publications (1)

Publication Number Publication Date
BE863368A true BE863368A (fr) 1978-07-26

Family

ID=9754946

Family Applications (1)

Application Number Title Priority Date Filing Date
BE184675A BE863368A (fr) 1977-01-26 1978-01-26 Nouveau vaccin

Country Status (20)

Country Link
US (2) US4320115A (sv)
JP (2) JPS5394084A (sv)
AT (1) AT368005B (sv)
BE (1) BE863368A (sv)
CA (1) CA1112167A (sv)
CH (2) CH659084A5 (sv)
DE (1) DE2803240B2 (sv)
DK (1) DK36378A (sv)
ES (2) ES466359A1 (sv)
FI (1) FI59812C (sv)
FR (1) FR2378859B1 (sv)
GB (1) GB1596653A (sv)
IE (1) IE46498B1 (sv)
IT (1) IT1192756B (sv)
LU (1) LU78951A1 (sv)
NL (1) NL174371C (sv)
NO (1) NO780156L (sv)
PT (1) PT67554B (sv)
SE (2) SE444453B (sv)
ZA (1) ZA78421B (sv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100752A3 (de) * 1982-08-04 1985-04-17 Veterinär-Bakteriologisches Institut der Universität Bern Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
CA1249518A (en) * 1985-09-06 1989-01-31 David Johnston Oral immunization of mammals
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
WO1995028175A1 (en) * 1994-04-19 1995-10-26 Thomas Jefferson University Viral ribonucleocapsid as an immunological enhancer
US6495360B1 (en) * 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
US20030118628A1 (en) * 2001-04-05 2003-06-26 Tutuncu Nurhan Pinar Confectionery product having a salivation region and an oral comfort region
CN112342185B (zh) * 2020-11-11 2022-12-02 深圳市卫光生物制品股份有限公司 一种鸡胚细胞狂犬病病毒的生物反应器工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1015262A (en) * 1962-02-09 1965-12-31 Nat Res Dev Virus culture
US3255080A (en) * 1962-08-06 1966-06-07 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
FR1567869A (sv) * 1967-06-22 1969-05-23
US4014991A (en) * 1976-01-23 1977-03-29 The United States Of America As Represented By The Department Of Health, Education And Welfare Oral rabies immunization of carnivores

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture

Also Published As

Publication number Publication date
PT67554A (en) 1978-02-01
CH658192A5 (de) 1986-10-31
ZA78421B (en) 1979-01-31
FR2378859A1 (sv) 1978-08-25
NL174371C (nl) 1984-06-01
FR2378859B1 (sv) 1980-08-29
IE46498B1 (en) 1983-06-29
SE8201768L (sv) 1982-03-19
JPS6225127B2 (sv) 1987-06-01
ES466359A1 (es) 1978-10-01
NL7800708A (nl) 1978-07-28
ES469937A1 (es) 1978-12-16
DE2803240A1 (de) 1978-08-10
GB1596653A (en) 1981-08-26
SE7800781L (sv) 1978-07-27
CH659084A5 (de) 1986-12-31
ATA52678A (de) 1982-01-15
AT368005B (de) 1982-08-25
DE2803240B2 (de) 1980-08-07
US4400472A (en) 1983-08-23
FI780184A (fi) 1978-07-27
IT7867143A0 (it) 1978-01-25
FI59812C (fi) 1981-10-12
FI59812B (fi) 1981-06-30
NO780156L (no) 1978-07-27
CA1112167A (en) 1981-11-10
JPS637754B2 (sv) 1988-02-18
IT1192756B (it) 1988-05-04
JPS5394084A (en) 1978-08-17
IE780161L (en) 1978-07-26
PT67554B (en) 1979-06-18
SE443924B (sv) 1986-03-17
US4320115A (en) 1982-03-16
JPS5877822A (ja) 1983-05-11
SE444453B (sv) 1986-04-14
LU78951A1 (fr) 1979-09-06
DK36378A (da) 1978-07-27

Similar Documents

Publication Publication Date Title
FI781613A (fi) Terapeutiska hydantoinfoereningar
FI781614A (fi) Terapeutiska aemnen
GB2009771B (en) Vaccine
SE7808607L (sv) Anordning for intravenos administrering
DK491877A (da) Sproejte
BE863914A (fr) Seringue laryngo-tracheale
SE7604818L (sv) Vaccin
FI783326A (fi) Terapeutiska aemnen
IT7849126A0 (it) Procedimento per ottenere vaccini acellulari potenziati
DK377478A (da) Antiperspirant-praeparat
GB2001530B (en) Vaccine
BE863368A (fr) Nouveau vaccin
DK151003C (da) Acaricidt praeparat
DK145614C (da) Lagerbestandigt cholesterinoxidasepraeparat
SE7813201L (sv) Vaccin
FI781123A (fi) Med pengar fungerande spelanordning
DK265378A (da) Vaccine
IT7847914A0 (it) Vaccino sinciziale respiratorio
SE7811192L (sv) Haemophilus influensa-vaccin
BE850141A (fr) Vaccin
SE7802840L (sv) Polysakaridframstellning
SE7800967L (sv) Fastsettningsmedel for tandvard
BE870728A (fr) Nouveau jouet
SE7807919L (sv) Fenolframstellning
BE827145A (fr) Vaccin

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GIST-BROCADES N.V.

Effective date: 19940131